COMS acquires DMS and is selected by Medline
The DMS Advance Care Directives functionality will be integrated and interfaced into the company's Daylight IQ™ disease management product suite.
COMS also announced on Tuesday that Medline Industries had selected COMS Daylight IQ Disease Management solution. The agreement “further enhances Medline's clinical product offering, with special emphasis on helping customers reduce hospital readmissions.” The exclusive agreement calls for joint marketing and sales initiatives.
“We are impressed with the excellent clinical and financial outcomes produced by COMS in individual facilities and large groups across the U.S., especially in the area of reducing hospital readmissions,” noted David Jacobs, president, Medline Post-Acute Care division.